Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Cabozantinib
Related studies linked through entity extraction aliases.
A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
caBozantinib in cOllectiNg ductS Renal Cell cArcInoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Precision Therapy in Refractory Tumor
- Status
- UNKNOWN
- Phase
- PHASE2
Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)
- Status
- COMPLETED
- Phase
- PHASE1